Recent Advances in Hypertensive Therapy

In addition to being a major risk factor for heart disease, stroke, and
kidney problems, hypertension is a substantial worldwide health
burden. Despite the fact that traditional antihypertensive
medications, including diuretics, beta-blockers, ACE inhibitors,
calcium channel blockers, and angiotensin receptor blockers,
successfully lower blood pressure, problems such as resistant
hypertension, side effects, and poor patient adherence still exist.
Novel pharmacological treatments such as enhanced
mineralocorticoid receptor antagonists, direct renin inhibitors, and angiotensin receptor–neprilysin inhibitors are the focus of recent developments in hypertension medicine. Treatment results and compliance have improved with fixed-dose combo treatments. Additionally, pharmacogenomics-supported personalized medicine techniques and device-based therapies like renal denervation are showing promise as ways to maximize the control of hypertension and enhance long-term cardiovascular outcomes.